SkyQuest projects that the cancer gene therapy market will attain a value of USD 12.63 billion by 2031, with a CAGR of 20.42% during the forecast period (2024-2031). Evolution in genetic research and therapeutic approaches have fostered a powerful growth in the cancer gene therapy market. Gene therapies enable targeted interventions at the genetic level,… Continue reading Cancer Gene Therapy Market to Lead at 20.42% CAGR by 2031 | Skyquest Technology